MB (6.65 ± 0.988 mg) and MI groups (5.95 ± 0.759 mg) were found to be lower than the NS group (6.95 ± 0.945 mg). Statistically, a significant difference was noticed in the dose requirement between NS and MI groups (p¼0.003) and also between MB and MI groups (p¼0.045). No statistically significant difference was found between NS and MB groups (p¼0.548). None of the patients in the study had delayed neuromuscular reversal.
Trends in obesity amongst patients undergoing general anaesthesia at Great Ormond Street Hospital for Children, London . Childhood obesity poses an increasing burden to healthcare resources and screening for obesity may help target these resources where they are most needed. This study aims to establish trends in the burden of paediatric obesity on general anaesthesia services, at a specialist children's hospital, over the past decade.
We performed a retrospective review of data obtained from the Patient Information Management System, including all patients aged 4e18 years undergoing general anaesthesia at Great Ormond Street Hospital, between 2006 and 2016. Variables included date of birth, date of procedure, gender, height and weight. Body Mass Index (BMI) was calculated using the standard equation. UK 1990 growth chart BMI data was obtained under licence from the UK Medical Research Council 4 . A linear regression model was constructed adjusting BMI for age, sex and year of measurement. The primary outcome was the percentage of obese patients, defined as a BMI above the 98th centile. 4 The institutional clinical audit and research governance departments deemed that the study did not require local research ethics committee approval and it was registered as a service evaluation (registration number 2055). All analyses were performed using R software version 3.3.2.
A total of 73399 patients aged 4e18 years underwent general anaesthesia from 1st January 2006 to 24th November 2016, of which height and weight data was available for 55170. After data cleaning 35977 patients were included in the final analysis, of which 4624 were obese (12.9%).
This study demonstrates no significant change in the prevalence of paediatric obesity over the 11 year period from January 2006 to November 2016 at Great Ormond Street Hospital, London. Despite this there was still a significant proportion of patients that were obese (12.9%) which represents an immediate perioperative risk 3 , as well as a longterm health and economic burden for individuals and healthcare services. Improving recognition of childhood obesity may enable the reduction of perioperative risk and the potential to intervene with the involvement of specialist obesity services. We recommend: (1.) Introduction of a care pathway to identify obesity in patients prior to general anaesthesia; (2.) Development of a perioperative protocol for the management of the obese child undergoing general anaesthesia; (3.) Introduction of a specialist obesity service.
Accidental awareness under general anaesthesia (AAGA) is an uncommon but particularly distressing complication, with potentially long-lasting psychological consequences. Over 400 reported cases of AAGA were reported during the fifth National Audit Project, with a projected incidence of 1:136000 general anaesthetics. 1 However, 97% of reported cases of AAGA were associated with the use of neuromuscular blocking drugs (NMBDs), an incidence of 1:8000 1 . Around one-fifth of these reported cases were at emergence with all patients experiencing residual neuromuscular blockade. Failure to use a peripheral nerve stimulator was seen as causal or at least contributory in half of these cases. The 2015 updated guidance from the Association of Anaesthetists of Great Britain and Ireland (AAGBI) 2 stated that a peripheral nerve stimulator must be used when a NMBD is given, as part of the minimum standards of monitoring during general anaesthesia. 2 We aimed to explore the current use of NMBDs, nerve stimulators and reversal agents during general anaesthesia in a UK teaching hospital. A retrospective anaesthetic chart review of patients receiving surgery under general anaesthesia was undertaken at Leicester Royal Infirmary. Information collected included patient characteristics, NMBD used and timings, use of a nerve stimulator and reversal agent.
Twenty nine patient anaesthetic charts post general anaesthetic and neuromuscular blockade drug have been reviewed to date. 11 male, mean age 50.8, 4 emergency procedures (14%) 25 elective procedures (86%), ASA 1-3. Atracurium was used in 62% of procedures and 87% of patients had a documented reversal agent administered. 14 charts (48%) had documented use of a peripheral nerve stimulator or neuromuscular monitoring peri-operatively. A Consultant e18 -Abstracts
